Pressure BioSciences Q2 revenue rises 70%, trend expected to continue
10:01 EDT 14 Aug 2012 | Proactive Investors
Pressure BioSciences (OTCQB: PBIO) said Tuesday second quarter revenue rose 70 per cent, attributed to growth in all three of its segments, with the trend expected to continue. The life sciences company is focused on the development and sale of propr..
Original Article: Pressure BioSciences Q2 revenue rises 70%, trend expected to continue
More From BioPortfolio on "Pressure BioSciences Q2 revenue rises 70%, trend expected to continue"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
